title: Antipsychotics for schizophrenia: the paradigm of psychiatric drugs.
abstract: Antipsychotic drugs do not appear to reverse the causes of schizophrenia, and although they can relieve symptoms in the short to medium term, in the long term they may not be beneficial and could even be counterproductive. Their use should be limited to acute situations in which agitation and tension is disabling. The drugs have significant adverse effects, and given the refusal of a person to continue taking them, a harm reduction strategy to support and monitor the withdrawal may be preferable to coercion. There are alternatives to neuroleptics. Prescribers should be more vigilant and consider the assessments of users regarding the drugs' effects. Adherence to treatment guidelines is low, probably because the guidelines are based on clinical trials of deficient quality which consequently should be improved and extended over a greater period of time. The root of the problem is likely the tautology on the etiology and biological nature of what is known as schizophrenia, which in fact does not seem to be more than a commercial and ideological construct.
authors: Unidad de Farmacia, Centro Dr. Esquerdo para Enfermos Mentales, Diputación Provincial de Alicante.
authors: Emilio
authors: E
authors: Pol Yanguas
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D055118:Medication Adherence; D012559:Schizophrenia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D016312:Treatment Refusal
chemical_list: D014150:Antipsychotic Agents
keywords: Schizophrenia; Antipsychotic Agents; Marketing; Effectiveness; Medication Adherence